Polysaccharide-Derived Drug Delivery Systems: Therapeutic Potential in Rheumatoid Arthritis—A Review
Open Access
- 29 September 2026
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (10) , 1545
Abstract
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic synovial inflammation, synovial hyperplasia, and progressive joint destruction and remains a major clinical challenge. Polysaccharide-derived delivery platforms have attracted widespread attention for RA precision therapy owing to their natural origin, excellent biocompatibility, and tailorable functionality; however, existing reviews generally focus on single material or carrier types and provide limited cross-comparison of carrier architectures and translational considerations. This review systematically evaluates recent advances in polysaccharide derivative design strategies and delivery system innovations for RA management. We first elaborate on how chemical modifications confer multi-responsive properties (pH-, reactive oxygen species [ROS]-, and enzyme-triggered release) and how diversified morphologies (hydrogels, microspheres, microneedles, vesicles) enable spatiotemporally controlled drug delivery in inflamed joints. Critical analysis highlights several translational barriers, including limited in vivo retention, insufficient pharmacokinetic and biodistribution data, and challenges associated with scale-up manufacturing and reproducibility. Looking forward, future development should integrate biomimetic design, rational multi-component optimization, and advanced manufacturing technologies to improve the stability, controllability, and translational feasibility of polysaccharide-based RA delivery systems. This review provides an integrated, translation-focused perspective that bridges material engineering and clinical pathological demands, guiding the development of next-generation polysaccharide-based RA therapies.Keywords
Funding Information
- Jiangsu Provincial Natural Science Foundation for Basic Research (BK20240493)
- Jiangsu University (KD2025QLJS002)
- National Natural Science Foundation of China (L244003)
- National Natural Science Foundation of China (52273119)
- People’s Liberation Army (BWS17J036)
- Nanjing Medical University (KD2024JXJH004)
This publication has 126 references indexed in Scilit:
- Multifunctional Nanocarrier Drug Delivery Systems: From Diverse Design to Precise Biomedical ApplicationsAdvanced Healthcare Materials, 2025
- Microneedle Assisted Melittin‐Chondroitin Sulfate Administration for the Transdermal Therapy of Rheumatoid ArthritisAdvanced Healthcare Materials, 2025
- Locally Injectable, ROS‐Scavenging, and ROS‐/pH‐Responsive Polymeric‐Micelles‐Embedded Hydrogels for Precise Minimally Invasive and Long‐Lasting Rheumatoid TherapyAdvanced Healthcare Materials, 2024
- Diversity and Clonality of T Cell Receptor Repertoire and Antigen Specificities in Small Joints of Early Rheumatoid ArthritisArthritis & Rheumatology, 2023
- 4D Printing of Hydrogels: A ReviewAdvanced Functional Materials, 2020
- Microsponge: An emerging drug delivery strategyDrug Development Research, 2018
- Increased hyperpolarized [1‐13C] lactate production in a model of joint inflammation is not accompanied by tissue acidosis as assessed using hyperpolarized 13C‐labelled bicarbonateNMR in Biomedicine, 2018
- Polysaccharide‐Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to BedsideAdvanced Science, 2018
- Dynamic Nanoparticle Assemblies for Biomedical ApplicationsAdvanced Materials, 2017
- Integration of Nanoassembly Functions for an Effective Delivery Cascade for Cancer DrugsAdvanced Materials, 2014